7-6446051-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_139179.4(DAGLB):āc.149C>Gā(p.Ala50Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,612,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_139179.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DAGLB | NM_139179.4 | c.149C>G | p.Ala50Gly | missense_variant | 2/15 | ENST00000297056.11 | NP_631918.3 | |
DAGLB | NM_001142936.2 | c.149C>G | p.Ala50Gly | missense_variant | 2/13 | NP_001136408.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DAGLB | ENST00000297056.11 | c.149C>G | p.Ala50Gly | missense_variant | 2/15 | 1 | NM_139179.4 | ENSP00000297056.6 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151582Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250620Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135556
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461290Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726980
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151582Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 73956
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 11, 2024 | The c.149C>G (p.A50G) alteration is located in exon 2 (coding exon 2) of the DAGLB gene. This alteration results from a C to G substitution at nucleotide position 149, causing the alanine (A) at amino acid position 50 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at